Results 221 to 230 of about 180,059 (262)
Some of the next articles are maybe not open access.
Modulation of Cardiac Hypertrophy by Estrogens
1997Gender-specific differences in heart disease have long been known but it has only been since the advent of molecular biology that it has become possible to investigate the molecular mechanisms. Most biochemical work in the last 50 years has focused on the characterization of the steroid hormones involved in gender specificity.
Pelzer, T. +4 more
openaire +4 more sources
Proto-Oncogenes And Cardiac Hypertrophy
Annual Review of Physiology, 1989Generalized or focal myocardial hypenrophy is a component of most types of cardiac disease. Abnormalities of this growth process, which include in adequate, idiopathic, and pathological hypertrophy, have great clinical sig nificance. Postnatal heart enlargement is produced largely by increased size of striated muscle cells (hypertrophy) and increased
openaire +2 more sources
Noncoding RNAs in Cardiac Hypertrophy
Journal of Cardiovascular Translational Research, 2018Cardiac hypertrophy is classified as pathological and physiological hypertrophy. Pathological hypertrophy typically precedes the onset of heart failure, one of the largest contributors to disease burden and deaths worldwide. In contrast, physiological hypertrophy is an adaptive response and protects against adverse cardiac remodeling.
Yongqin, Li +4 more
openaire +2 more sources
Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential
Nature Reviews Cardiology, 2023Thomas G Martin +2 more
exaly
The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure
Cell Metabolism, 2021Stephen Mckellar +2 more
exaly
USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes
Circulation Research, 2023Guang Liang, Bozhi Ye, Weijian Huang
exaly
Position-specific oxidation of miR-1 encodes cardiac hypertrophy
Nature, 2020Haejeong Lee +2 more
exaly